Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists (Q46690279)

24 December 2017

title

Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists (English)

1 reference

24 December 2017

0 references

1 reference

O'Dell SJ

1

1 reference

24 December 2017

Weihmuller FB

series ordinal

2

1 reference

24 December 2017

Marshall JF

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

24 December 2017

Journal of Neurochemistry

published in

1 reference

24 December 2017

volume

60

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

1792-1799

1 reference

24 December 2017

Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Evidence for carrier-mediated efflux of dopamine from corpus striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1993.TB13405.X

10.1111/J.1471-4159.1993.TB13405.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

8473897

1 reference

24 December 2017